Opioid receptor active compounds

Details Opioid receptor active compounds Opioid receptor active compounds

2006-05-16

2006-05-16

Shameem, Golam M. M. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S111000, C544S132000, C544S336000, C544S358000, C544S366000, C546S184000, C546S210000, C548S262200, C548S264800

Reexamination Certificate

active

07045520

ABSTRACT:
The invention provides compounds of formula I:wherein R1to R4and n have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I, and therapeutic methods for treating pain and treating other conditions which involve, for example, binding opioid receptors using compounds of formula I.

REFERENCES:
patent: 4481360 (1984-11-01), Gall et al.
patent: 4512997 (1985-04-01), Meier et al.
patent: 5108486 (1992-04-01), Kondo et al.
patent: 5310724 (1994-05-01), Kondo et al.
patent: 2269938 (1975-12-01), None
patent: WO-99/14204 (1999-03-01), None
patent: WO-00/14066 (2000-03-01), None
Suzuki et al (2000): STN International CAPLUS database, Columbus (Ohio): Accession No.: 2000L 136274.
Abdelhamid, E. E., et al.,J. Pharmacol. Exp. Ther., 258, (1991),299.
Bilsky, E. J., et al.,J. Pharmacol. Exp. Ther., 273, (1995),359.
Clemence, F., et al., “Synthese Et Activate Analgesique Dans La Serie Des Triazoles-1,2,4”,European Journal of Medicinal Chemistry, 20, Editions Scientifique Elsevier, Paris, FR, (1985), 257-266.
House, R. V., et al.,Neurosci. Lett., 198, (1995), 119.
Koji, Ohsumi, et al., “Synthesis and Antitumor Activity of Cisrestricted Combretastatins: 5-Membered Heterocyclic Analogues”,Bioorganic&Medicinal Chemistry Letters, 8, Oxford, GB, (1998), 3153-3158.
Lange, L , et al., “4(H)-1,2,4-Triazole Derivatives with Expected Biological Activity”,Dissertations Pharmaceuticae and Pharmacologicae, 22, (1970), 217-221.
Reid, L. D., et al.,Life Sciences, 52, (1993), PL 67.
Schiller, P. W., et al.,J. Med. Chem., 42, (1999), 3520.
Snyder, S H., et al., “Historical Review: Opioid Receptors”,Trends in Pharmacological Sciences, 24, Elsevier, Amsterdam, NL, (Apr. 2003), 198-205.

Affiliated with

Also associated with

Rating

Opioid receptor active compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Opioid receptor active compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opioid receptor active compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3592576